Related references
Note: Only part of the references are listed.Precise editing of FGFR3-TACC3 fusion genes with CRISPR-Cas13a in glioblastoma
Ye Wu et al.
MOLECULAR THERAPY (2021)
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
Patrick Y. Wen et al.
NEURO-ONCOLOGY (2020)
HSP90 Inhibition Drives Degradation of FGFR2 Fusion Proteins: Implications for Treatment of Cholangiocarcinoma
Dante Lamberti et al.
HEPATOLOGY (2019)
FGF18, a prominent player in FGF signaling, promotes gastric tumorigenesis through autocrine manner and is negatively regulated by miR-590-5p
Jinglin Zhang et al.
ONCOGENE (2019)
Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair
Jianhui Ma et al.
CANCER CELL (2019)
First-in-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients with Advanced Solid Tumors
Akihiko Shimomura et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Coexisting FGFR3 p.K650T mutation in two FGFR3-TACC3 fusion glioma cases
Leomar Y. Ballester et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Targeting chromatin complexes in fusion protein-driven malignancies
Gerard L. Brien et al.
NATURE REVIEWS CANCER (2019)
A metabolic function of FGFR3-TACC3 gene fusions in cancer
Veronique Frattini et al.
NATURE (2018)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2018)
Oncogenic driver FGFR3-TACC3 is dependent on membrane trafficking and ERK signaling
Katelyn N. Nelson et al.
Oncotarget (2018)
Advances in the molecular genetics of gliomas - implications for classification and therapy
Guido Reifenberger et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance
Alison M. Schram et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
How Hsp90 and Cdc37 Lubricate Kinase Molecular Switches
Kliment A. Verba et al.
TRENDS IN BIOCHEMICAL SCIENCES (2017)
FGFR3-TACC3 cancer gene fusions cause mitotic defects by removal of endogenous TACC3 from the mitotic spindle
Sourav Sarkar et al.
OPEN BIOLOGY (2017)
Oncogenic Gene Fusion FGFR3-TACC3 Is Regulated by Tyrosine Phosphorylation
Katelyn N. Nelson et al.
MOLECULAR CANCER RESEARCH (2016)
Clonal evolution of glioblastoma under therapy
Jiguang Wang et al.
NATURE GENETICS (2016)
Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma
Anna Luisa Di Stefano et al.
CLINICAL CANCER RESEARCH (2015)
Maximizing the Therapeutic Potential of HSP90 Inhibitors
Lisa M. Butler et al.
MOLECULAR CANCER RESEARCH (2015)
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
Daniel J. Brat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The Fibroblast Growth Factor signaling pathway
David M. Ornitz et al.
WILEY INTERDISCIPLINARY REVIEWS-DEVELOPMENTAL BIOLOGY (2015)
The emerging complexity of gene fusions in cancer
Fredrik Mertens et al.
NATURE REVIEWS CANCER (2015)
Recurrent FGFR3-TACC3 fusion gene in nasopharyngeal carcinoma
Li Yuan et al.
CANCER BIOLOGY & THERAPY (2014)
Identification of Recurrent FGFR3-TACC3 Fusion Oncogenes from Lung Adenocarcinoma
Marzia Capelletti et al.
CLINICAL CANCER RESEARCH (2014)
Temozolomide resistance in glioblastoma cells occurs partly through epidermal growth factor receptor-mediated induction of connexin 43
J. L. Munoz et al.
CELL DEATH & DISEASE (2014)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Oncogenic FGFR3 gene fusions in bladder cancer
Sarah V. Williams et al.
HUMAN MOLECULAR GENETICS (2013)
Molecular Mechanism of 17-Allylamino-17-demethoxygeldanamycin (17-AAG)-induced AXL Receptor Tyrosine Kinase Degradation
Gnana Prakasam Krishnamoorthy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Coordination of adjacent domains mediates TACC3-ch-TOG-clathrin assembly and mitotic spindle binding
Fiona E. Hood et al.
JOURNAL OF CELL BIOLOGY (2013)
Identification of recurrent FGFR3 fusion genes in lung cancer through kinome-centred RNA sequencing
Ian J. Majewski et al.
JOURNAL OF PATHOLOGY (2013)
Tyrosine kinase gene rearrangements in epithelial malignancies
Alice T. Shaw et al.
NATURE REVIEWS CANCER (2013)
Quantitative Analysis of Hsp90-Client Interactions Reveals Principles of Substrate Recognition
Mikko Taipale et al.
CELL (2012)
Improved survival time trends for glioblastoma using the SEER 17 population-based registries
Matthew Koshy et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma
Devendra Singh et al.
SCIENCE (2012)
The Physical Basis of FGFR3 Response to fgf1 and fgf2
Fenghao Chen et al.
BIOCHEMISTRY (2011)
Fibroblast Growth Factor Receptor 3 (FGFR3) Is a Strong Heat Shock Protein 90 (Hsp90) Client IMPLICATIONS FOR THERAPEUTIC MANIPULATION
Melanie B. Laederich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Inhibition of 90-kD heat shock protein potentiates the cytotoxicity of chemotherapeutic agents in human glioma cells Laboratory investigation
Shigeo Ohba et al.
JOURNAL OF NEUROSURGERY (2010)
Targeting the dynamic HSP90 complex in cancer
Jane Trepel et al.
NATURE REVIEWS CANCER (2010)
Fibroblast growth factor signalling: from development to cancer
Nicholas Turner et al.
NATURE REVIEWS CANCER (2010)
Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology
Lonneke A. M. Gravendeel et al.
CANCER RESEARCH (2009)
Mislocalized Activation of Oncogenic RTKs Switches Downstream Signaling Outcomes
Chunaram Choudhary et al.
MOLECULAR CELL (2009)
Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells
Claire Marie-Elisabeth Sauvageot et al.
NEURO-ONCOLOGY (2009)
The impact of translocations and gene fusions on cancer causation
Felix Mitelman et al.
NATURE REVIEWS CANCER (2007)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex
WP Xu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2005)
Roles of N-linked glycans in the endoplasmic reticulum
A Helenius et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2004)
Share Paper
